Filing Flows › Axsome Therapeutics (AXSM) › Recalls, complaints & regulation
Axsome Therapeutics (AXSM): clinical trials
Axsome Therapeutics (AXSM) beyond its filings: 12 active clinical trials.
Axsome Therapeutics' latest quarter
Axsome Therapeutics, Q3 2026: revenue $260M (+52% year over year), operating margin -4.3%, net loss $12.9M, operating cash flow −$9.5M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Axsome Therapeutics have?
12 active studies on ClinicalTrials.gov, 10 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.